कृपया अन्य खोज का प्रयास करें
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company’s checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Jason J. Luke | - | 2021 | Member of Scientific Advisory Board |
Robert Ross | - | - | Director |
Paul J. Clancy | 61 | 2020 | Non-Employee Independent Chairman |
Anthony J. O’Donoghue | - | - | Member of Scientific Advisory Board |
Deborah Charych | 58 | - | Member of Scientific Advisory Board |
Christina Rossi | 46 | 2021 | Independent Director |
Yuan Xu | 55 | 2022 | Independent Director |
Daniel Curran | 55 | 2020 | Independent Director |
Kwok-Kin Wong | - | 2021 | Member of Scientific Advisory Board |
Andy Minn | - | 2021 | Member of Scientific Advisory Board |
Jason J. Luke | - | 2021 | Member of Scientific Advisory Board |
Robert W. Ross | 49 | 2022 | Independent Director |
Christopher A. Hunter | - | - | Member of Scientific Advisory Board |
Jamie Spangler | - | 2021 | Member of Scientific Advisory Board |
Sara M. Bonstein | 42 | 2021 | Independent Director |
Tomas J. Heyman | 67 | 2022 | Independent Director |
Rene Russo | 48 | 2019 | President, CEO & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है